VCEL

Vericel

39.71

+0.41+1.04%

After Hours: 39.87 +0.16 +0.40%19:30 09/25 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE39.67/40.05

TODAY RANGE39.50-41.40

VOL647.00K

MARKET CAP2.09B

52 WEEK RANGE28.95-49.32

AVG VOL (3M)505.39K

% TURNOVER1.00%

TURNOVER--

P/E (TTM)97.51

% RANGE4.51%

EPS(TTM)0.4178

P/E(FORWARD)73.74

P/B5.63

BVPS7.23

DIVIDEND--

P/S7.46

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP2.06B

SHARES OUTSTANDING51.21M

NEXT EARNINGS11/04-11/09

FREE FLOAT50.59M

LOT SIZE1

EX-DATE10/16/2013

News

Press Releases

Financial Reports

Profile

TipRanks·09/22 12:30
Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD)
TipRanks·09/18 12:35
Leerink Partners Sticks to Their Buy Rating for Vericel (VCEL)
Seeking Alpha·09/15 03:47
Vericel: MACI And Regenerative Knee Cartilage
TipRanks·09/04 11:30
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (DNA) and Vericel (VCEL)
TipRanks·08/20 11:40
Wall Street Analysts Are Bullish on Top Healthcare Picks
NASDAQ·08/10 12:40
3 Major Earnings Winners You May Have Missed
Dow Jones·07/31 17:41
Vericel Is Maintained at Buy by TD Cowen
Dow Jones·07/31 13:40
Vericel Price Target Raised to $58.00/Share From $54.00 by Truist Securities
TipRanks·07/31 12:55
Vericel price target raised to $58 from $55 at TD Cowen
TipRanks·07/31 11:47
Truist Financial Reaffirms Their Buy Rating on Vericel (VCEL)
Dow Jones·07/31 10:19
Vericel Price Target Raised to $72.00/Share From $70.00 by HC Wainwright & Co.
Dow Jones·07/31 10:19
Vericel Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·07/30 11:56
*Vericel Raises 2026 View To Rev $330M-$340M >VCEL
Dow Jones·07/30 11:55
Press Release: Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program
Dow Jones·07/30 11:55
*Vericel Board of Directors Authorizes $200M Share-Repurchase Program >VCEL

Same Industry

Name/Symbol

Change%

Price

Vericel

VCEL

+1.04%

39.71

McKesson

MCK

-0.56%

874.65

Biogen Inc

BIIB

+0.55%

227.60

Amgen Inc

AMGN

-3.38%

407.27

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-12.41%

0.1094

Lilly Eli & Co

LLY

+0.04%

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

+0.46%

2.190

Johnson & Johnson

JNJ

-0.10%

269.19

Abbvie Inc

ABBV

-0.02%

263.96

Zoetis Inc

ZTS

+0.54%

71.44

Gilead Sciences Inc

GILD

-1.87%

144.74

Novo-Nordisk A/S

NVO

+0.47%

38.80

Bristol-Myers Squibb Co

BMY

-0.70%

62.62

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

+0.29%

27.74

Sanofi FR

SNY

+0.42%

41.11

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

+1.32%

145.46

Dr Reddys Labs

RDY

0.00%

12.19

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.